ValiRx plc (LON:VAL – Get Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 0.24 and traded as low as GBX 0.15. ValiRx shares last traded at GBX 0.15, with a volume of 3,467,012 shares.
ValiRx Price Performance
The firm has a market capitalization of £1.98 million, a PE ratio of -0.28 and a beta of 0.59. The company has a current ratio of 4.62, a quick ratio of 1.27 and a debt-to-equity ratio of 0.05. The company has a fifty day moving average price of GBX 0.17 and a two-hundred day moving average price of GBX 0.24.
ValiRx (LON:VAL – Get Free Report) last released its quarterly earnings results on Monday, June 22nd. The company reported GBX (0.54) earnings per share (EPS) for the quarter. ValiRx had a negative return on equity of 70.79% and a negative net margin of 7,115.36%.The firm had revenue of GBX 3 million for the quarter. Sell-side analysts forecast that ValiRx plc will post -1.74 earnings per share for the current year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
